Research Ethics and Commercial Drug Development: When Integrity Threatens Profitability

Authors

  • Jean-Christophe Bélisle Pipon Bioethics Program, Department of Social and Preventive Medicine, School of Public Health, Université de Montréal, Montréal, Québec, Canada

DOI:

https://doi.org/10.7202/1044268ar

Keywords:

business ethics, clinical trials, corporate decision-making, drug development, profitability, research ethics, venture capital

Language(s):

English

Abstract

This case, based on personal experiences and on those found in the literature, highlights the delicate tension faced by drug development companies having to balance research integrity and their profitability.

Downloads

Published

2016-05-12

Issue

Vol. 5 (2016)

Section

Case studies

License

Copyright (c) 2016 Jean-Christophe Bélisle Pipon

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.